Biomarkers for Detecting Premalignant Effects and Responses to Protective Therapies during Critical Windows of Development
Circulating molecular and cellular biomarkers in cancer
Chiodi I;Mondello C
2018
Abstract
Biomarkers for Detecting Premalignant Effects and Responses to Protective Therapies during Critical Windows of DevelopmentFile in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
